Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
Based on available data, the concept of neo-adjuvant chemotherapy seems to be promising for
patients with resectable non-small cell lung cancer. The exploration of new drugs and
regimens are warranted. Therefore the aim of this study is to evaluate the clinical response
rate of neo-adjuvant chemotherapy with gemcitabine and cisplatin in patients with operable
non-small cell lung cancer stage IB, IIA-B, IIIA.